SCHEMBL14294653

SCHEMBL14294653

CC(C)[C@H](NC(=O)CBr)C(=O)OCCN1C(=O)CCC(N2C(=O)c3ccccc3C2=O)C1=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAP1LC3B Q9GZQ8 3/20 0.39
KMT2A Q03164 3/20 0.35
IL1RN P18510 1/20 0.34
ERAP2 Q6P179 1/20 0.34
ERAP1 Q9NZ08 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
DDB1 Q16531 4/20 0.33
CRBN Q96SW2 4/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
HPGD P15428 1/20 0.33
GAA P10253 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CHRM2 P08172 1/20 0.33
OPRM1 P35372 1/20 0.33
IKZF3 Q9UKT9 1/20 0.33
CYP1A2 P05177 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14142180 1.00 MAP1LC3B (0.39) MAP1LC3BKMT2AIL1RNERAP2ERAP1
SCHEMBL2919213 0.91 CYP3A4 (0.39) MAP1LC3BKMT2AIL1RNERAP2ERAP1
SCHEMBL2915694 0.91 CYP3A4 (0.39) MAP1LC3BKMT2AIL1RNERAP2ERAP1
SCHEMBL14141937 0.90 MAP1LC3B (0.36) MAP1LC3BKMT2AIL1RNERAP2ERAP1
SCHEMBL14294711 0.90 MAP1LC3B (0.36) MAP1LC3BKMT2AIL1RNERAP2ERAP1
Hydrochloric Acid SCHEMBL14142396 0.89 MAP1LC3B (0.36) MAP1LC3BKMT2AIL1RNERAP2ERAP1
SCHEMBL14142265 0.86 DDB1 (0.42) MAP1LC3BKMT2ADDB1CRBN
SCHEMBL14294652 0.86 DDB1 (0.42) MAP1LC3BKMT2ADDB1CRBN
SCHEMBL14142181 0.86 KMT2A (0.37) MAP1LC3BKMT2ADDB1CRBNTDP1
SCHEMBL14294654 0.83 PREP (0.42) MAP1LC3BL3MBTL1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637545-B2 Piperidine-2, 6-dione derivatives and their use as tumor necrosis factor inhibitors TIANJIN HEMAY BIO-TECH CO., LTD. (CN) 2014-01-28 US disclosed
US-20080051432-A1 PIPERIDINE-2, 6-DIONE DERIVATIVES AND THEIR USE AS TUMOR NECROSIS FACTOR INHIBITORS TIANJIN HEMAY PHARMACEUTICAL CO., LTD. (CN) 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051432-A1 PIPERIDINE-2, 6-DIONE DERIVATIVES AND THEIR USE AS TUMOR NECROSIS FACTOR INHIBITORS TNF, TNFRSF1A, TNFRSF9 MAP1LC3B 4651/4885KMT2A 4780/4885IL1RN 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.